SHUKRAMEDShukra Medtech Limited

Convert to idea

Healthcare · Drug Manufacturers - Specialty & Generic

Buy, hold or avoid?

The verdict combines business quality, price and timing. Sign in free to see it.

Sign in free

Valuation Metrics

Q2 FY2027
Market Cap
₹2,737 Cr
EPS
₹1.02
PE (TTM)
N/Ax
P/B Ratio
30.79x
PEG Ratio
N/A
ROE
37.33%
Intrinsic Val
N/A
Fair value

Intrinsic value, Graham number and DCF against today's price

Red flags

1 found · risk minor

Score breakdown

Quality, growth, balance sheet and earnings quality behind the score

Data confidence — what this verdict is based on
Completenessmissing growth
History depth7 quarters — limited trend
FreshnessQ2 FY2027, filed 53d ago
Consistencyfigures internally consistent

ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.

Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.